Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1FED 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 1

Interventions

Imiquimod 2Docetaxel 2Celecoxib 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2pembrolizumab 1pasireotide 1gadolinium ethoxybenzyl DTPA 1enzalutamide 1Uterine Myomectomy 1Topotecan 1Tablets 1Sildenafil Citrate 1Reference Standards 1Pentoxifylline 1Mindfulness 1Mass Screening 1Ketoconazole 1Itraconazole 1Hysterectomy 1Hypnosis 1Herpes Zoster Vaccine 1Fecal Microbiota Transplantation 1Exercise 1Estramustine 1Epirubicin 1Doxycycline 1Cryotherapy 1Biopsy, Large-Core Needle 1Azacitidine 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × FED × gadolinium ethoxybenzyl DTPA × Clear all
NCT01341132 2011-04-25

Evaluation of Cirrhosis and Malignant Hepatic Lesions Using Novel MR Contrast Agents

San Francisco Veterans Affairs Medical Center

Unknown
75 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡